NIKKEI 225
39,042.44 +425.34 (+1.10%) HANG SENG
18,869.86 -325.74 (-1.70%) CRUDE OIL
76.93 -0.64 (-0.83%) GOLD FUTURES
2,368.50 -24.40 (-1.02%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,511.02 -365.32 (-0.67%)
LifeMD, Inc. (LFMD)
After hours:
| Previous close | 7.71 |
| Open | 7.70 |
| Bid | 7.78 x 400 |
| Ask | 7.81 x 400 |
| Day's range | 7.59 - 7.82 |
| 52-week range | 1.93 - 12.88 |
| Volume | |
| Avg. volume | 820,319 |
| Market cap | 329.439M |
| Beta (5Y monthly) | 1.39 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance
First quarter revenue increased 33% year-over-year to $44.1 million with telehealth revenue growing 53% versus the year-ago period.Raising full-year revenue guidance to at least $205 million, up from prior guidance of at least $200 million.Growth in all business segments, with weight management subscribers growing to 42,000 as of March 31, 2024. As of today, weight management subscribers exceed 50,000.Including the increase in deferred revenue from prepaid weight management subscriptions, cash-a
- GlobeNewswire
LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition
LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomesNEW YORK and BOSTON, May 02, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc.® (Nasdaq: LFMD), a leading provider of virtual primary care services, and Withings Health Solutions, a leader in digital health technology, announce a new strategic partnership designed to revolutionize weight management patient care by providing LifeMD’s GLP-1 weight-loss p
- GlobeNewswire
LifeMD Appoints Dr. Calum MacRae to its Board of Directors
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors. “We are delighted to welcome Dr. MacRae to the LifeMD Board of Directors. He brings deep experience in cardiology, internal medicine and clinical innovation, with a focus on disease management an
